Unprotected left main disease managed with drug-eluting stents: Long-term outcome of 100 patients with increased surgical risk

Catheterization and Cardiovascular Interventions

Volumn 71, Issue 4, 2008, Pages 533-538

  Wood, Frances O ^a   Saylors, Elizabeth K ^a   Schneider, Joel E ^a   Jobe, R Lee ^a   Mann III, J Tift ^a,b  

^a Wake Heart Center   (United States)

^b Wake Heart Associates   (United States)

Author keywords

Drug eluting stents; High surgical risk; Percutaneous coronary intervention; Unprotected left main stenting

Indexed keywords

CLOPIDOGREL; PACLITAXEL; RAPAMYCIN; CARDIOVASCULAR AGENT;

AGED; ARTICLE; CONTROLLED STUDY; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART DEATH; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; RESTENOSIS; RISK FACTOR; SURVIVAL; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; HEART INFARCTION; HOSPITALIZATION; INSTRUMENTATION; KAPLAN MEIER METHOD; MORTALITY; PATIENT SELECTION; RETROSPECTIVE STUDY; RISK ASSESSMENT; TIME; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CARDIOVASCULAR AGENTS; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MYOCARDIAL INFARCTION; PACLITAXEL; PATIENT SELECTION; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SIROLIMUS; TIME FACTORS; TREATMENT OUTCOME;

EID: 41649089162     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.21447     Document Type: Article

References (26)

1. Chieffo A, Stankovic G, Bonizzoni E, et al. Early and mid-term results of drug-eluting stent implantation in unprotected left main. Circulation 2005;111:791-795.
2. Park S, Kim Y, Lee B, et al. Sirolimus-eluting stent implantation for unprotected left main coronary artery stenosis: Comparison with bare metal stent implantation. J Am Coll Cardiol 2005;45:351-356.
3. Valgimigli M, van Mieghem C, Ong A, et al. Short and long-term clinical outcome after drug-eluting stent implantation for the percutaneous treatment of left main coronary artery disease: Insights from the Rapamycin-Eluting and Taxus Stent Evaluated At Rotterdam Cardiology Hospital registries (RESEARCH and T-SEARCH). Circulation 2005;111:1383-1389.
4. Lee M, Kapoor N, Jamal F, et al. Comparison of coronary artery bypass surgery with percutaneous coronary intervention with drug-eluting stents for unprotected left main coronary artery disease. J Am Coll Cardiol 2006;47:864-870.
5. Price M, Cristea E, Sawhney N, et al. Serial angiographic follow-up of sirolimus-eluting stents for unprotected left main coronary artery revascularization. J Am Coll Cardiol 2006;47:971-977.
6. Wood F, Bazemore E, Mann T, et al. Technique of the left main stenting is dependent on lesion location and distal branch protection. Catheter Cardiovasc Interv 2005;65:499-503.
7. Migliorini A, Moschi G, Giurlani L, et al. Drug-eluting stent supported percutaneous coronary intervention for unprotected left main disease. Catheter Cardiovasc Interv 2006;68:225-230.
8. Sanmartin M, Baz J, Lozano I, et al. One-year results of unprotected left main disease treatment with paclitaxel-eluting stents: Results of a multi-center registry. Catheter Cardiovasc Interv 2007;69:372-377.
9. Fajadet J, Serrys P, Colombo A, Sheiban I, Seabra-Games R, Barragan P. Clinical and angiographic outcomes one year after elective implantation of sirolimus-eluting stents in unprotected left main coronary arteries: Final results of an European retrospective multi-center study. (abstract). Am J Cardiol 2006;98:Suppl30M.
10. Lefevre T, Darremont O, Morice M, et al. One-year outcome of the left main TAXUS pilot study. (abstract). Am J Cardiol 2006;98:Suppl29M.
11. Chieffo A, Morici N, Maisano F, et al. Percutaneous treatment with drug-eluting stent implantation versus bypass surgery for unprotected left main stenosis: A single-center experience. Circulation 2006;113:2542-2547.
12. Nashef S, Roques F, Michael P, Gauducheau E, Lemeshow S, Salamon R, the EuroSCORE study group. European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg 1999;16:9-13.
13. Nashef S, Roques F, Hammill B, et al. Validation of the European system for cardiac operation risk evaluation (EuroSCORE) in North American surgery. Eur J DV Surg 2002;22:101-105.
14. Kim Y, Ahn J, Park D, et al. EuroSCORE as a predictor of death and myocardial infarction after unprotected left main coronary stenting. Am J Cardiol 2006;98:1568-1570.
15. Colombo A, Stankovic G, Orlic D, et al. Modified T-stenting technique with crushing for bifurcation lesions: Immediate results and 30-day outcome. Catheter Cardiovasc Interv 2003;60:145-151.
16. Cutlip D, Windecker S, Mehran R, et al. Clinical end points in coronary stent trials: A case for standardized definitions. Circulation 2007;115:2344-2351.
17. Palmerini T, Marzocchi A, Marrozzini C, et al. Comparison between coronary angioplasty and coronary artery bypass surgery for the treatment of unprotected left main coronary artery stenosis (the Bologna Registry). Am J Cardiol 2006;98:54-59.
18. Chieffo A, Park S, Valgimigli M. Favorable long term outcome after drug-eluting stent implantation in nonbifurcation lesions that involve unprotected left main coronary artery: A multicenter registry. Circulation 2007;116:158-162.
19. Erglis A, Narbute I, Kumsars I, et al. A randomized comparison of paclitaxel-eluting stents versus bare-metal stents for treatment of unprotected left main coronary artery stenosis. J Am Coll Cardiol 2007;50:491-497.
20. Baim DS, Mauri L, Cutlip DC. Drug-eluting stenting for unprotected left main coronary artery disease: are we ready to replace bypass surgery? J Am Coll Cardiol 2006;47:878-881.
21. Stone GW, Moses JW, Leon MB. Left main drug-eluting stents: Natural progression or a bridge too far? J Am Coll Cardiol 2007;50:498-500.
22. Smith SC Jr, Feldman TE, Hirshfeld JW Jr, et al. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention - Summary article: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). Circulation 2006;113:156-175.
23. Park S, Hong M, Lee C, et al. Elective stenting of unprotected left main coronary artery stenosis: Effect of debulking before stenting and intravascular ultrasound guidance. J Am Coll Cardiol 2001;38:1054-1060.
24. Seung K, Kim Y, Park D, et al. Effectiveness of sirolimus-eluting stent implantation for the treatment of ostial left anterior descending artery stenosis with intravascular ultrasound guidance. J Am Coll Cardiol 2005;46;787-792.
25. Dangas G, Stone G, Leon M, et al. Assessing intermediate left main coronary lesions: Lessons learned from intravascular ultrasound. (abstract). Am J Cardiol 2006;98:S27-S31.
26. Fassa A, Wagatsuma K, Higano S, et al. Intravascular ultrasound-guided treatment for angiographically indeterminate left main coronary artery disease: A long-term follow-up study. J Am Coll Cardiol 2005;45:204-211.